News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novacea, Inc. (NOVC) Says Not to Develop Drug after FDA Lifts Hold


9/10/2008 3:32:48 PM

Sept 11 (Reuters) - Novacea Inc said it will not develop its cancer drug Asentar even after U.S. health regulators released the clinical hold on it, sending the biopharmaceutical company's shares to a lifetime low. The company, which agreed to be acquired by privately held Transcept Pharmaceuticals Inc earlier this month, had terminated the late-stage study of Asentar in November 2007 due to an unexplained imbalance of deaths between the treatment and control arms of the trial.

Read at BioSpace.com
Read at Reuters

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES